Skip to main content

and
  1. Article

    Open Access

    Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14–3-3η/NF-κB feedback loop

    Multi-drug resistance (MDR) is one of the main obstacles for treatment of advanced/recurrent hepatocellular carcinoma (HCC). We have previously identified arsenic trioxide (ATO) as an effective metastasis/angi...

    Yongxin Qiu, Yi Dai, Chi Zhang, Ye Yang in Journal of Experimental & Clinical Cancer … (2018)

  2. Article

    Open Access

    Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α

    Sorafenib resistance is one of the main obstacles to the treatment of advanced/recurrent hepatocellular carcinoma (HCC). Here, sorafenib-resistant HCC cells and xenografts in nude mice were used as experimenta...

    Yongxin Qiu, Wenqi Shan, Ye Yang, Ming **, Yi Dai, Hanyu Yang in Cell Death Discovery (2019)